NCT07067983Recruiting
Clinical Evaluation of GRAPE Model for Gastric Cancer Screening
Source: ClinicalTrials.gov · Last updated 16 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000000 (estimated)
- First submitted
- 6 Jul 2025
- Start date
- 30 May 2025
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Zhejiang Cancer Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07067983
What you commit to
- Study type: Observational
- Planned participants: 1000000
- From 30 May 2025 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with confirmed diagnosis of gastric cancer
- Individuals with severe intellectual disabilities or communication disorders
Who the study is looking for
- Aged between 18 and 80 years
- Individuals undergoing thoracoabdominal CT examination
- Voluntarily participated in the study and provided written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.